Yusuf Sherwani, Pelago founder and CEO

Pela­go rais­es $58M to ex­pand on­line sub­stance use treat­ment

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Pela­go, which pro­vides dig­i­tal sub­stance use treat­ment for sub­stances like opi­oids and to­bac­co, said it is ex­pand­ing to cov­er more sub­stances as em­ploy­ers seek out a dig­i­tal so­lu­tion to low­er costs.

The start­up on Thurs­day said it raised $58 mil­lion in Se­ries C fund­ing, bring­ing its to­tal to $151 mil­lion. It sends pa­tients re­mote mon­i­tor­ing de­vices such as breath­a­lyz­ers, pro­vides vir­tu­al ac­cess to physi­cians and coach­es, and pre­scribes med­ica­tion if need­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.